仙乐健康拟启动H股发行 计划赴港交所主板上市

Core Viewpoint - Xianle Health is planning to issue H-shares and list on the Hong Kong Stock Exchange, marking a significant step in its globalization strategy and potentially becoming the first A+H listed company in the nutrition and health industry [1][2] Group 1: Company Overview - Xianle Health, established in 1993, is a leading global provider of comprehensive solutions for nutrition and health products, offering services that include research and product development, manufacturing, packaging, logistics, and marketing support [1] - The company was listed on the Shenzhen Stock Exchange's ChiNext board on September 25, 2019, becoming the first A-share listed CDMO enterprise in the nutrition and health food sector [1] Group 2: Strategic Focus - The company is focused on the trends of health consumption upgrades and aims to enhance customer service, research innovation, and agile supply chain competitive barriers [1] - Xianle Health is strategically targeting high-potential global markets and is building a global operational network that emphasizes "headquarters empowerment and regional deep cultivation" to drive replicable and scalable business [1] Group 3: Fundraising Purpose - The funds raised from the H-share issuance will be used to optimize production capacity in key regional markets, strengthen core competitiveness, accelerate the construction of new productive forces, supplement working capital, and enhance the company's capital strength and overall influence [2]